An interventional study of Comprehensive Chronic Care and Standard Care in Smoking Cessation and Smoking Abstinence, sponsored by University of Wisconsin, Madison. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Smoking Cessation by University of Wisconsin, Madison — 3 open to participants now, 3 under way, none of them phase 3. Smoking Cessation · University of Wisconsin, Madison.
Among the 33 studies in Smoking Cessation by University of Wisconsin, Madison, this one is the 10th largest by enrollment of the 32 interventional ones that give a count, is one of 2 that started in 2022, is one of 13 with no phase, and was the 24th registered.
1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.
Browse Smoking Cessation studies →3 of the 33 studies in Smoking Cessation by University of Wisconsin, Madison are open now, in 1 country. Recruiting first, the newest first:
University of Wisconsin, Madison · Sites in United States
Ages 21+ · Healthy volunteers
University of Wisconsin, Madison · Sites in United States
Ages 21+
University of Wisconsin, Madison · Sites in United States
Ages 21+
By country, each count listing its studies:
Of the 134 Smoking Cessation studies recruiting now, 92 (69%) set no upper age limit and 35 (26%) stop at 75 or younger; 6 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 2 started in 2022.
This study's enrollment of 979 is above the median of 163 across 1,425 interventional studies indexed under Smoking Cessation.
Median enrollment 561 across the 32 interventional studies, 16 across the 1 observational. Of the 29 that completed or were terminated, 23 (79%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 33 studies in Smoking Cessation by University of Wisconsin, Madison, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate Comprehensive Chronic Care (CCC), a healthcare treatment approach designed to increase smoking treatment engagement and abstinence among primary care patients who smoke. This research will compare CCC with Standard of Care (SC) on the following outcomes: abstinence at 18 months (primary outcome), treatment reach, and cost-effectiveness. Participation in the study will last 18 months.
This project is a 2-arm randomized controlled trial (RCT) designed to evaluate whether Comprehensive Chronic Care (CCC), relative to Standard Care (SC), increases smoking abstinence and treatment use in primary care patients who smoke. The aims are as follows:
Primary Aim
Secondary Aims
Comprehensive Chronic Care (CCC) provides ongoing proactive outreach designed to provide support and information about evidence-based smoking treatment, with access to individually validated treatments that are appropriate for patients who are: 1) unwilling quit but willing to reduce; 2) ready to quit; and 3) recovering from an unsuccessful quit attempt.
Standard Care (SC) involves one offer of cessation treatment per year (8 weeks of nicotine patch plus referral to the tobacco quit line).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ongoing proactive outreach designed to provide support and information about evidence-based smoking treatment, with access to individually validated treatments that are appropriate for patients who are: 1) unwilling quit but willing to reduce; 2) ready to quit; and 3) recovering from an unsuccessful quit attempt
Other: Comprehensive Chronic Care
involves one offer of cessation treatment (8 weeks of nicotine patch plus referral to the tobacco quit line), annually
Other: Standard Care
Those randomized to CCC will receive smoking treatment offers via the following routes: 1) Four Outreach Calls from a Health Counselor at 4, 8, 12, and 14 months post-study enrollment; 2) Four texts and/or mailings (depending on healthcare system preferences) over 14 months. These outreach contacts will offer cessation treatment or reduction treatment.
one offer of cessation treatment annually
Number of Participants With Biochemically Confirmed Point-prevalence Abstinence at 18 Months
Group differences in abstinence at 18 months will be evaluated using intent-to-treat principle.
Time frame: up to 18 months
Number of Participants With 7-day Point-prevalence Abstinence at 6 Months
At 6 months, participants will be asked whether they have smoked in the past 7 days. Group differences in abstinence at 6 months will be evaluated using intent-to-treat principle.
Time frame: 6 months
Number of Participants With 7-day Point-prevalence Abstinence at 12 Months
At 12 months, participants will be asked whether they have smoked in the past 7 days. Group differences in abstinence at 12 months will be evaluated using intent-to-treat principle.
Time frame: 12 months
Group Differences in Cessation Treatment
Group differences in cessation treatment entry (i.e., Number of participants who initiated greater than 0 cessation treatment calls vs. number of participants who initiated 0 calls).
Time frame: Up to 18 months
Total Cost of Intervention
Incremental resource costs related to the CCC intervention include Health Counselor/staff time, administration, staff training, recruitment, and medication. Methods recommended by the United States Panel on Cost-Effectiveness in Health and Medicine will be utilized. Costs will be measured from a societal perspective using direct observational data of health system resource use. Cost estimates will be converted to a common year.
Time frame: Up to 18 months
Cost Effectiveness Measured by Incremental Cost-effectiveness Ratio (ICER)
Cost per additional person who quits smoking, for the CCC vs. SC. The ICER is calculated as the difference in total costs between CCC and SC divided by the difference in 18-month quit rates.
Time frame: Up to 18 months
| Milestone | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| Started | 589 | 390 |
| Completed | 514 | 364 |
| Not completed | 75 | 26 |
| Withdrew: Withdrawal by subject | 54 | 19 |
| Withdrew: Withdrawn by pi | 4 | 0 |
| Withdrew: Death | 14 | 7 |
| Withdrew: Incarcerated | 3 | 0 |
Group differences in abstinence at 18 months will be evaluated using intent-to-treat principle.
| Participants | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| Number of Participants With Biochemically Confirmed Point-prevalence Abstinence at 18 Months | 47 | 37 |
At 6 months, participants will be asked whether they have smoked in the past 7 days. Group differences in abstinence at 6 months will be evaluated using intent-to-treat principle.
| Participants | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| Smoked in past 7 days | 490 | 353 |
| Abstinent in past 7 days | 99 | 37 |
At 12 months, participants will be asked whether they have smoked in the past 7 days. Group differences in abstinence at 12 months will be evaluated using intent-to-treat principle.
| Participants | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| Smoked in past 7 days | 499 | 343 |
| Abstinent in past 7 days | 90 | 47 |
Group differences in cessation treatment entry (i.e., Number of participants who initiated greater than 0 cessation treatment calls vs. number of participants who initiated 0 calls).
| Participants | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| Participated in Greater Than 0 Cessation Treatment Calls | 353 | 250 |
| Participated in 0 Cessation Treatment Calls | 236 | 140 |
Incremental resource costs related to the CCC intervention include Health Counselor/staff time, administration, staff training, recruitment, and medication. Methods recommended by the United States Panel on Cost-Effectiveness in Health and Medicine will be utilized. Costs will be measured from a societal perspective using direct observational data of health system resource use. Cost estimates will be converted to a common year.
Results for this outcome have not been posted.
Cost per additional person who quits smoking, for the CCC vs. SC. The ICER is calculated as the difference in total costs between CCC and SC divided by the difference in 18-month quit rates.
Results for this outcome have not been posted.
Collected over Adverse event data were collected from Target Quit Date until end of cessation period, up to 12 weeks. Non-serious events are listed at a 4% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Comprehensive Chronic Care | 14/589 (2.4%) | 70/589 (11.9%) | 213/589 (36.2%) |
| Standard Care | 7/390 (1.8%) | 47/390 (12.1%) | 16/390 (4.1%) |
| Event | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| HospitalizationSurgical and medical procedures | 12/589 | 16/390 |
| HospitalizationInfections and infestations | 13/589 | 7/390 |
| HospitalizationGastrointestinal disorders | 8/589 | 3/390 |
| HosptitalizationCardiac disorders | 7/589 | 3/390 |
| HospitalizationVascular disorders | 6/589 | 3/390 |
| HospitalizationNervous system disorders | 5/589 | 3/390 |
| HospitalizationPsychiatric disorders | 2/589 | 3/390 |
| HospitalizationMusculoskeletal and connective tissue disorders | 4/589 | 0/390 |
| HospitalizationGeneral disorders | 4/589 | 0/390 |
| HospitalizationInjury, poisoning and procedural complications | 3/589 | 2/390 |
| Event | Comprehensive Chronic Care | Standard Care |
|---|---|---|
| InsomniaPsychiatric disorders | 46/589 | 3/390 |
| NauseaGastrointestinal disorders | 41/589 | 2/390 |
| HeadacheNervous system disorders | 29/589 | 2/390 |
| IndigestionGastrointestinal disorders | 28/589 | 0/390 |
| Itch or hivesSkin and subcutaneous tissue disorders | 24/589 | 4/390 |
| Vivid dreamsPsychiatric disorders | 23/589 | 3/390 |
| Sore throatGeneral disorders | 22/589 | 2/390 |
| Age, Continuous(Years) | Comprehensive Chronic Care | Standard Care | Total |
|---|---|---|---|
| Mean | 53.233 ± 13.0261 | 54.023 ± 13.1302 | 53.547 ± 13.0667 |
| Sex/Gender, Customized(Participants) | Comprehensive Chronic Care | Standard Care | Total |
|---|---|---|---|
| Female | 332 | 219 | 551 |
| Male | 255 | 171 | 426 |
| Other | 2 | 0 | 2 |
| Race (NIH/OMB)(Participants) | Comprehensive Chronic Care | Standard Care | Total |
|---|---|---|---|
| American Indian or Alaska Native | 4 | 3 | 7 |
| Asian | 2 | 3 | 5 |
| Native Hawaiian or Other Pacific Islander | 1 | 1 | 2 |
| Black or African American | 68 | 61 | 129 |
| White | 473 | 290 | 763 |
| More than one race | 19 | 16 | 35 |
| Unknown or Not Reported | 22 | 16 | 38 |
| Ethnicity (NIH/OMB)(Participants) | Comprehensive Chronic Care | Standard Care | Total |
|---|---|---|---|
| Hispanic or Latino | 32 | 13 | 45 |
| Not Hispanic or Latino | 557 | 375 | 932 |
| Unknown or Not Reported | 0 | 2 | 2 |
| Self-report Smoking in last 7 days at Baseline(Participants) | Comprehensive Chronic Care | Standard Care | Total |
|---|---|---|---|
| Count of participants | 589 | 390 | 979 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Aug 2022 to primary completion in Sep 2025, 37 months.
Results were first posted in Nov 2026, 1 year 1 month after primary completion.
Of 547 non-industry interventional studies with no phase under Smoking Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 37 months is above that.
Counting every sponsor, half of 564 studies reached it within 24 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →